Objective:To investigate the clinical curative effect of valsartan combined with Shenyankangfu tablet in female glomerulonephritis patients.Methods:72 female glomerulonephritis patients in our hospital from January 2014 to December 2015 were selected and randomly divided into the control group and experiment group,36 cases each group.The patients in control group were treated with Valsartan and the patients in experiment group were given valsartan combined with Shenyankangfu tablet.The blood pressure,24 h urinary protein,serum Scr,BUN,Hb,and the incidence of adverse reactions were compared before and after treatment.Results:After 12 weeks of treatment,compared with the control group,the 1 uantitative levels of systolic blood pressure,diastolic blood pressure and 24 h urinary protein were lower in experiment group (P ＜0.05),and the serum Scr and BUN levels were lower in experiment group (P＜0.05),but the Hb level was higher (P＜0.05),the effective rate was higher in the experiment group (P＜0.05).Conclusions:Valsartan combined with Shenyankangfu tablet has good clinical efficacy and safety in female patients with glomerulonephritis and proteinuria,it can effectively reduce blood pressure and urine protein,decrease SCR and BUN level and elevate Hb level,worthy of clinical application and promotion.
NETL
NSTL
万方数据
维普
